BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19097661)

  • 1. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models.
    Christian N; Lee JA; Bol A; De Bast M; Jordan B; Grégoire V
    Radiother Oncol; 2009 Apr; 91(1):101-6. PubMed ID: 19097661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.
    Christian N; Deheneffe S; Bol A; De Bast M; Labar D; Lee JA; Grégoire V
    Radiother Oncol; 2010 Nov; 97(2):183-8. PubMed ID: 20304513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.
    Geets X; Tomsej M; Lee JA; Duprez T; Coche E; Cosnard G; Lonneux M; Grégoire V
    Radiother Oncol; 2007 Oct; 85(1):105-15. PubMed ID: 17562346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
    Differding S; Sterpin E; Janssens G; Hanin FX; Lee JA; Grégoire V
    Acta Oncol; 2016; 55(2):217-25. PubMed ID: 26079436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
    El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic evaluation of 18F-FDG uptake by microPET and whole-body autoradiography in a fibrosarcoma-bearing mouse model.
    Chang CH; Fan KH; Chen TJ; Hsu WC; Jan ML; Tsai TH; Kao PF; Chen CF; Fu YK; Lee TW
    J Formos Med Assoc; 2004 Nov; 103(11):876-81. PubMed ID: 15549159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilization device for in vivo and in vitro multimodality image registration of rodent tumors.
    Christian N; Lee JA; Bol A; De Bast M; Gallez B; Grégoire V
    Radiother Oncol; 2008 Apr; 87(1):147-51. PubMed ID: 18359528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of concept.
    Axente M; He J; Bass CP; Sundaresan G; Zweit J; Williamson JF; Pugachev A
    Radiother Oncol; 2014 Feb; 110(2):309-16. PubMed ID: 24486116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
    Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
    Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a radiotherapy target with positron emission tomography.
    Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
    Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
    Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls.
    Roels S; Slagmolen P; Nuyts J; Lee JA; Loeckx D; Maes F; Vandecaveye V; Stroobants S; Ectors N; Penninckx F; Haustermans K
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):782-90. PubMed ID: 19289265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
    Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
    J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.